Oral GLP-1 treatments
Explore the researchResearch Guides
Research GuidesSemaglutide tablets, drops and lozenges: ask for formulation-specific evidenceA guide to separating approved oral products from compounded preparations and unsupported evidence transfers.Read guide →Research GuidesFood, water and other tablets: build the routine around the exact productWhy oral semaglutide and Foundayo need separate administration checklists, with practical questions for a pharmacist.Read guide →Research GuidesMedication review before an oral GLP-1 switchPrepare the product history, interaction questions and written handoff needed before changing an oral GLP-1 medicine.Read guide →Research GuidesOral semaglutide and physical function: look beyond the scaleUnderstand OASIS 4’s patient-reported physical-function endpoint and how to discuss meaningful daily-life goals.Read guide →Research GuidesWhy oral GLP-1 trial percentages do not form a rankingRead OASIS, PIONEER and ATTAIN results by population, dose, comparator and analysis before comparing products.Read guide →Research GuidesWhy oral semaglutide depends on its formulationUnderstand SNAC, exposure and why a tablet study cannot validate an unrelated oral preparation.Read guide →Research GuidesOral semaglutide and liver impairment: drug exposure is not liver-treatment efficacyA pharmacokinetic study answers a different question from a MASH trial or a long-term safety study.Read guide →Research GuidesOral GLP-1 medicines are not all the same kind of moleculeCompare peptide semaglutide tablets and small-molecule orforglipron by product, indication and daily routine.Read guide →Research GuidesOral semaglutide alongside insulin: an add-on study is not a replacement planUnderstand PIONEER 8’s combination-treatment question and the clinical handoff needed before changing an insulin-based plan.Read guide →Research GuidesOral semaglutide with reduced kidney function: what PIONEER 5 testedDistinguish glucose-control evidence in moderate renal impairment from a long-term kidney-outcome claim.Read guide →Research GuidesTablet versus injection: what the liraglutide comparison actually establishedRead PIONEER 4’s noninferiority result without turning one direct comparison into a verdict on all oral and injectable GLP-1 medicines.Read guide →Research GuidesOral semaglutide versus sitagliptin: make the comparison match the goalPIONEER 3 provides a direct tablet comparison in a defined diabetes population, with separate glucose, weight and tolerability questions.Read guide →